MAA
ARIA

Managed Account Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Managed Account Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-211
Closed -$1K – 3111
2014
Q4 		$1K Buy
+211
New +$1.32K ﹤0.01% 2703
2014
Q1 		– Sell
-3,721
Closed -$25K – 2679
2013
Q4 		$25K Sell
3,721
-497,147
-99% -$2.68M ﹤0.01% 2433
2013
Q3 		$9.22M Buy
500,868
+44,124
+10% +$857K 0.01% 953
2013
Q2 		$7.99M Buy
+456,744
New +$8.1M 0.01% 975

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Managed Account Advisors's ARIA Position: Q1 2015 in Review

Managed Account Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2015, closing a stake of 211 shares — an estimated $1K sold.

Managed Account Advisors first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $9.22M in Q3 2013. 193 funds tracked by Wall St. Rank hold ARIA as of Q1 2015.

  • Managed Account Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Managed Account Advisors sold 211 Ariad Pharmaceuticals Inc shares in Q1 2015, an estimated $1K.
  • Managed Account Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Managed Account Advisors's Ariad Pharmaceuticals Inc position peaked at $9.22M in Q3 2013.
  • 193 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2015.

Based on Managed Account Advisors's 13F filing for Q1 2015, filed 15 May 2015.